Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Disease Markers
|
December 3, 2003
Assessment of cancer-associated biomarkers by positron emission tomography: advances and challenges
T Lee Collier, Roger Lecomte, Timothy J McCarthy, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 20, 2012
Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans
Jenna M Sullivan, Keunpoong Lim, David Labaree, et al.
Diabetologia
|
May 4, 2018
Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging
Gary W Cline, Mika Naganawa, Laigao Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2020
PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [<sup>18</sup>F]PF-06684511
Ryosuke Arakawa, Akihiro Takano, Per Stenkrona, et al.
Neuroimage
|
May 22, 2014
Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242
Mika Naganawa, Leslie K Jacobsen, Ming-Qiang Zheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 6, 2015
Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans
Eunkyung Park, Jenna M Sullivan, Beata Planeta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 12, 2018
Quantitative Analysis of <sup>18</sup>F-PF-06684511, a Novel PET Radioligand for Selective β-Secretase 1 Imaging, in Nonhuman Primate Brain
Akihiro Takano, Laigao Chen, Sangram Nag, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Olivier Barret, Lei Zhang, David Alagille, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 11, 2012
In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET
Marc D Normandin, Kitt F Petersen, Yu-Shin Ding, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 22, 2016
Determination of receptor occupancy in the presence of mass dose: [<sup>11</sup>C]GSK189254 PET imaging of histamine H<sub>3</sub> receptor occupancy by PF-03654746
Jean-Dominique Gallezot, Beata Planeta, Nabeel Nabulsi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Disease Markers
|
December 3, 2003
Assessment of cancer-associated biomarkers by positron emission tomography: advances and challenges
T Lee Collier, Roger Lecomte, Timothy J McCarthy, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 20, 2012
Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans
Jenna M Sullivan, Keunpoong Lim, David Labaree, et al.
Diabetologia
|
May 4, 2018
Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging
Gary W Cline, Mika Naganawa, Laigao Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2020
PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [<sup>18</sup>F]PF-06684511
Ryosuke Arakawa, Akihiro Takano, Per Stenkrona, et al.
Neuroimage
|
May 22, 2014
Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242
Mika Naganawa, Leslie K Jacobsen, Ming-Qiang Zheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 6, 2015
Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans
Eunkyung Park, Jenna M Sullivan, Beata Planeta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 12, 2018
Quantitative Analysis of <sup>18</sup>F-PF-06684511, a Novel PET Radioligand for Selective β-Secretase 1 Imaging, in Nonhuman Primate Brain
Akihiro Takano, Laigao Chen, Sangram Nag, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Dopamine D<sub>1</sub> Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Olivier Barret, Lei Zhang, David Alagille, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 11, 2012
In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET
Marc D Normandin, Kitt F Petersen, Yu-Shin Ding, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 22, 2016
Determination of receptor occupancy in the presence of mass dose: [<sup>11</sup>C]GSK189254 PET imaging of histamine H<sub>3</sub> receptor occupancy by PF-03654746
Jean-Dominique Gallezot, Beata Planeta, Nabeel Nabulsi, et al.
Page
of 4